Literature DB >> 24010395

Pituitary adenomas: an overview.

Marcy G Lake1, Linda S Krook, Samya V Cruz.   

Abstract

Prolactinomas and nonfunctioning adenomas are the most common types of pituitary adenomas. Patients with pituitary adenomas may present initially with symptoms of endocrine dysfunction such as infertility, decreased libido, and galactorrhea, or with neurologic symptoms such as headache and visual changes. The diagnosis may also be made following imaging done for an unrelated issue in an asymptomatic patient; this is termed a pituitary incidentaloma. Oversecretion of hormones from a dysfunctional pituitary gland may result in classic clinical syndromes, the most common of which are hyperprolactinemia (from oversecretion of prolactin), acromegaly (from excess growth hormone), and Cushing disease (from overproduction of adrenocorticotropic hormone). In the diagnostic approach to a suspected pituitary adenoma, it is important to evaluate complete pituitary function, because hypopituitarism is common. Therapy for pituitary adenomas depends on the specific type of tumor, and should be managed with a team approach to include endocrinology and neurosurgery when indicated. Dopamine agonists are the primary treatment for prolactinomas. Small nonfunctioning adenomas and prolactinomas in asymptomatic patients do not require immediate intervention and can be observed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24010395

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  38 in total

Review 1.  Ophthalmic manifestations of endocrine disorders-endocrinology and the eye.

Authors:  Alisha Kamboj; Michael Lause; Priyanka Kumar
Journal:  Transl Pediatr       Date:  2017-10

2.  Role of pituitary stalk and gland radiological status on endocrine function and outcome after endoscopic transsphenoidal surgery for non-functioning pituitary adenomas.

Authors:  C Vivancos Sánchez; A Palpán Flores; V Rodríguez Domínguez; A Zamarrón Pérez; C Álvarez-Escolá; C Pérez López
Journal:  Endocrine       Date:  2021-04-20       Impact factor: 3.633

3.  Classification and volumetric study of the sphenoid sinus on MDCT images.

Authors:  Busra Pirinc; Zeliha Fazliogullari; Ibrahim Guler; Nadire Unver Dogan; Ismihan Ilknur Uysal; Ahmet Kagan Karabulut
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-13       Impact factor: 2.503

4.  Changes in the peripapillary and subfoveal choroidal vascularity index after transsphenoidal surgery for pituitary macroadenoma.

Authors:  Yasin Özcan; Alp Kayıran; Fahrettin Kelestimur; Gazanfer Ekinci; Uğur Türe
Journal:  Int Ophthalmol       Date:  2022-05-23       Impact factor: 2.031

5.  The impact of endoscopic transsphenoidal pituitary adenoma surgery on endocrine function: a single-centre study.

Authors:  Luke Galloway; Mohamed Ali; Andrew Lansdown; Peter Taylor; Aled Rees; John Stephen Davies; Caroline Hayhurst
Journal:  Acta Neurochir (Wien)       Date:  2020-10-21       Impact factor: 2.216

6.  Surgical management of skull base tumors.

Authors:  Leonardo Rangel-Castilla; Jonathan J Russin; Robert F Spetzler
Journal:  Rep Pract Oncol Radiother       Date:  2014-10-14

7.  Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1.

Authors:  M Jian; Q Du; D Zhu; Z Mao; X Wang; Y Feng; Z Xiao; H Wang; Y Zhu
Journal:  J Endocrinol Invest       Date:  2018-10-28       Impact factor: 4.256

Review 8.  Machine learning applications in imaging analysis for patients with pituitary tumors: a review of the current literature and future directions.

Authors:  Ashirbani Saha; Samantha Tso; Jessica Rabski; Alireza Sadeghian; Michael D Cusimano
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

Review 9.  Pituitary Adenomas: From Diagnosis to Therapeutics.

Authors:  Samridhi Banskota; David C Adamson
Journal:  Biomedicines       Date:  2021-04-30

10.  TBX15 rs98422, DNM3 rs1011731, RAD51B rs8017304, and rs2588809 Gene Polymorphisms and Associations With Pituitary Adenoma.

Authors:  Gabija JuknytĖ; Inga LaurinaitytĖ; Alvita VilkeviČiŪtĖ; Greta GedvilaitĖ; Brigita GlebauskienĖ; Loresa KriauČiŪnienĖ; Rasa LiutkeviČienĖ
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.